News & Press Releases
Integrity Applications Spotlights GlucoTrack®Model DF-F Glucose Monitoring Device on World Diabetes Day 2013
November 14th, 2013
http://www.businesswire.com/news/home/20131113006801/en Integrity Applications Spotlights GlucoTrack®Model DF-F Glucose Monitoring Device on World Diabetes Day 2013 Device Offers Global Diabetes Community the Ability To Obtain Blood Glucose Measurements Non-Invasively November 14, 2013 01:00 AM Eastern Standard Time ASHKELON, Israel–(BUSINESS WIRE)–Integrity Applications, Inc. (OTCQB:IGAP), developer of the GlucoTrack®model DF-F non-invasive blood glucose measurement device, acknowledged World Diabetes Day […]
Read MoreIntegrity Applications to Present at the AMIZINO Fall 2013 Small Cap/Micro Cap Investment Conference
October 29th, 2013
Integrity Applications to Present at the AMIZINO Fall 2013 Small Cap/Micro Cap Investment Conference Press Release: Integrity Applications, Inc. – 10 hours ago RELATED QUOTES Symbol Price Change IGAP 8.50 0.00 ASHKELON, Israel–(BUSINESS WIRE)– Integrity Applications, Inc. (IGAP), developer of the GlucoTrack®model DF-F non-invasive blood glucose measurement device, announced that Avner Gal, the Company’s […]
Read MoreIntegrity Applications to Present and Exhibit at the 2013 Meeting of the European Association for the Study of Diabetes in Barcelona
September 24th, 2013
Integrity Applications to Present and Exhibit at the 2013 Meeting of the European Association for the Study of Diabetes in Barcelona CEO Avner Gal Will Present Poster on GlucoTrack® DF-F Monitoring Device ASHKELON, Israel – September 24, 2013 — Integrity Applications, Inc. (OTCQB: IGAP), developer of the GlucoTrack® model DF-F non-invasive blood glucose measurement device, […]
Read More DownloadIntegrity Applications, Inc. (OTC/QB: IGAP) announced today that it has received CE Mark approval for its GlucoTrack® DF-F non-invasive blood glucose measurement device.
June 4th, 2013
INTEGRITY APPLICATIONS RECEIVES CE MARK APPROVAL FOR ITS GLUCOTRACK® MODEL DF-F GLUCOSE MONITORING DEVICE ASHKELON, Israel (June 4, 2013) – Integrity Applications, Inc. (OTC/QB: IGAP) announced today that it has received CE Mark approval for its GlucoTrack® DF-F non-invasive blood glucose measurement device. Receipt of the CE Mark allows Integrity Applications to market and sell […]
Read More DownloadINTEGRITY APPLICATIONS COMMON STOCK IS PUBLICLY QUOTED ON THE OTC BULLETIN BOARD UNDER THE SYMBOL “IGAP”
April 10th, 2013
INTEGRITY APPLICATIONS COMMON STOCK IS PUBLICLY QUOTED ON THE OTC BULLETIN BOARD UNDER THE SYMBOL “IGAP” Raises approximately $6.3 million to advance the development and commercialization of GlucoTrack® for the non-invasive measurement of blood glucose ASHKELON, Israel (April 9, 2013) – Integrity Applications, Inc. (OTCQB:IGAP), developer of the GlucoTrack DF-F non-invasive blood glucose […]
Read More DownloadIntegrity applications has been certified to ISO 13485:2003 standard.
March 14th, 2013
Read More DownloadFrost & Sullivan Recognizes Integrity Applications for Path-Breaking Technology Innovation…
July 16th, 2008
Frost & Sullivan Recognizes Integrity Applications for Path-Breaking Technology Innovation and Growth Potential in the Non-Invasive Glucose Monitoring Markets PALO ALTO, Calif.–(Business Wire)– Based on its recent analysis of the biosensors market, Frost & Sullivan recognizes Integrity Applications Ltd. with the 2008 North American Frost & Sullivan Product Innovation Leadership of the Year Award for developing the […]
Read More
